Patient selection is a key factor in the safe and effective administration of advanced pain management modalities.
This guide discusses the integration of continuous glucose monitoring (CGM) technology into clinical practice, emphasizing the role of pharmacists in selecting and optimizing CGM devices for patients.
The story of gepirone may spark new conversations for industry standards on drug development to facilitate future innovations.
Panelists discuss how key recommendations for optimizing bispecific therapy care focus on establishing robust communication protocols between academic and community centers while ensuring community centers develop comprehensive infrastructure including staff training, emergency protocols, and care coordination pathways.
Experts give important background information on respiratory syncytial virus (RSV), as well as the key clinical considerations that are associated with RSV vaccine use.
Idaho State University partners with the Idaho Immunization Coalition to effectively and safely vaccinate patients against influenza.
Well-defined core values can take pharmacy operations to the next level.
As the pandemic has continued, it has helped shine a light on how important pharmacists, pharmacy interns, and pharmacy technicians can help impact their communities.
Pharmaceutical companies are looking into AI as the new method to not only reduce research and development costs, but also prevent costly errors.
Federal legislation would seek to foster development of antibiotics.
Pharmacy students can provide education, patient advocacy, and medication access.
Improved workflow and optimal patient outcomes occur when technicians serve as vital members of the health care team, across the continuum of care.
Systemic treatment options have historically been limited to traditional chemotherapy agents.
This article reviews the efficacy and safety data for bispecific T-cell engagers and the practical considerations for their implementation across various types of practice sites for the historically difficult-to-treat relapsed/refractory B-cell lymphoma population.
Metformin has been shown to decrease pro-inflammatory cytokines that appear to improve the immune response to tumor cells and improve the efficacy of immunotherapy.
Outpatient ASPs remain crucial amid rising antimicrobial resistance.
Educating the public about the dangers of self-medication and the importance of finishing prescribed antibiotic courses plays a crucial role
Despite demonstrating numerous benefits, semaglutide has also been linked to an increased incidence of diabetic retinopathy, which was initially reported in the SUSTAIN-6 trial.
Better access to prescription drugs improves patients’ experience, adherence, and health.
Pharmacists' roles in community-based cancer centers are expanding, with a more significant role in managing complex treatment regimens, ensuring comprehensive patient care, navigating drug shortages, and collaborating with multidisciplinary teams to enhance patient outcomes and streamline health care operations.
The conversation of VLR has sparked a discussion as to whether or not other COVID-19 treatment agents are associated with a surge in symptoms and if so, how those agents compare with the rebound effect of nirmatrelvir/ritonavir.
Conducting clinical trials to investigate claims regarding supplements' safety and efficacy can support greater patient wellness.
Continued advancements in therapy may expand its use to larger patient population, though challenges remain
Pharmacogenomics can play a role in lowering the cost of health care expenditures, such as shortening hospital stays and reducing emergency department visits.
AI and other technologies, in conjunction with ASHP’s guidelines, can improve drug diversion monitoring and outcomes.
Chicago Tylenol murders still reverberates after 40 years; they changed medication packaging forever.
Antimicrobial stewardship efforts focusing on accurate penicillin allergy histories, β-lactam cross-reactivity education, and guideline-driven narrow-spectrum prescribing may help sustainably decrease health care–associated Clostridioides difficile infection rates.
Pediatric guidelines suggest 10 days of therapy for community-acquired pneumonia, but recent data support shortening therapy duration.
As data continue to develop in this arena, β-lactam therapeutic drug monitoring is likely to become more routine, as it has with drugs like vancomycin and the aminoglycosides.